• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白原纳米胶囊作为一种药物传递系统,可提高利培酮的抗精神病活性。

Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone.

机构信息

The Institute of Nanotechnology and Advanced Materials, Department of Chemistry, Bar-Ilan University, Ramat-Gan 5290002, Israel.

Pre-Clinical Research Center: Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 5290002, Israel.

出版信息

Molecules. 2020 Sep 2;25(17):4013. doi: 10.3390/molecules25174013.

DOI:10.3390/molecules25174013
PMID:32887463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7504754/
Abstract

Risperidone (RSP) is an atypical antipsychotic drug widely used to treat schizophrenia and bipolar disorder. Nanoparticles (NPs) are being developed as in vivo targeted drug delivery systems, which cross the blood-brain barrier and improve pharmacokinetics and drug effectiveness. Here, biodegradable proteinoids were synthesized by thermal step-growth polymerization from the amino acids l-glutamic acid, l-phenylalanine and l-histidine and poly (l-lactic acid). Proteinoid NPs containing RSP were then formed by self-assembly, overcoming the insolubility of the drug in water, followed by PEGylation (poly ethylene glycol (PEG) conjugation to increase the stability of the NPs in the aqueous continuous phase. These NPs are biodegradable owing to their peptide and ester moieties. They were characterized in terms of diameter, size distribution, drug loading, and long-term storage. Behavioral studies on mice found enhanced antipsychotic activity compared to free RSP.

摘要

利培酮(RSP)是一种广泛用于治疗精神分裂症和双相情感障碍的非典型抗精神病药物。纳米颗粒(NPs)正在被开发为体内靶向药物递送系统,以穿越血脑屏障并改善药代动力学和药物功效。在这里,通过氨基酸 l-谷氨酸、l-苯丙氨酸和 l-组氨酸与聚(l-乳酸)的热逐步聚合合成了可生物降解的蛋白原。然后通过自组装形成含有 RSP 的蛋白原 NPs,克服了药物在水中的不溶性,随后进行 PEG 化(聚乙二醇(PEG)缀合以增加 NPs 在水连续相中的稳定性。这些 NPs 由于其肽和酯部分而具有生物降解性。对其粒径、粒径分布、载药量和长期储存进行了表征。对小鼠的行为研究发现,与游离 RSP 相比,其具有增强的抗精神病活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/7b87f0391b98/molecules-25-04013-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/64e036910615/molecules-25-04013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/8fd41c0ac873/molecules-25-04013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/a490dab160be/molecules-25-04013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/278746e48b30/molecules-25-04013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/8c52f775d922/molecules-25-04013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/b0aee04017bd/molecules-25-04013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/912ddd60ea8b/molecules-25-04013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/7deb2a97e139/molecules-25-04013-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/7b87f0391b98/molecules-25-04013-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/64e036910615/molecules-25-04013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/8fd41c0ac873/molecules-25-04013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/a490dab160be/molecules-25-04013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/278746e48b30/molecules-25-04013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/8c52f775d922/molecules-25-04013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/b0aee04017bd/molecules-25-04013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/912ddd60ea8b/molecules-25-04013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/7deb2a97e139/molecules-25-04013-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1013/7504754/7b87f0391b98/molecules-25-04013-g009.jpg

相似文献

1
Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone.蛋白原纳米胶囊作为一种药物传递系统,可提高利培酮的抗精神病活性。
Molecules. 2020 Sep 2;25(17):4013. doi: 10.3390/molecules25174013.
2
Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity.设计用于包裹利培酮以增强抗精神病活性的类蛋白聚合物和纳米颗粒。
J Nanobiotechnology. 2020 Oct 21;18(1):149. doi: 10.1186/s12951-020-00709-z.
3
Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications.用于药物递送应用的阿霉素封装及TRAIL偶联的聚(RGD)类蛋白纳米胶囊的工程设计
Polymers (Basel). 2020 Dec 16;12(12):2996. doi: 10.3390/polym12122996.
4
Synthesis and Characterization of Poly(RGD) Proteinoid Polymers and NIR Fluorescent Nanoparticles of Optimal d,l-Configuration for Drug-Delivery Applications- Study.用于药物递送应用的聚(RGD)类蛋白聚合物及具有最佳d,l构型的近红外荧光纳米颗粒的合成与表征——研究
ACS Omega. 2020 Sep 11;5(37):23568-23577. doi: 10.1021/acsomega.0c01916. eCollection 2020 Sep 22.
5
Encapsulation of clozapine in polymeric nanocapsules and its biological effects.氯氮平在聚合物纳米胶囊中的包封及其生物学效应。
Colloids Surf B Biointerfaces. 2016 Apr 1;140:342-352. doi: 10.1016/j.colsurfb.2015.12.044. Epub 2016 Jan 6.
6
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.经鼻给予利培酮固体脂质纳米粒实现脑靶向。
J Drug Target. 2011 Jul;19(6):468-74. doi: 10.3109/1061186X.2010.523787. Epub 2010 Oct 19.
7
Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.通过逐层自组装制备对映体聚丙交酯立体复合物包覆的磁铁矿纳米载体用于高度可调谐药物递送
ACS Appl Mater Interfaces. 2016 Jan 27;8(3):1842-53. doi: 10.1021/acsami.5b09822. Epub 2016 Jan 12.
8
Engineering of NIR fluorescent PEGylated poly(RGD) proteinoid polymers and nanoparticles for drug delivery applications in chicken embryo and mouse models.用于鸡胚和小鼠模型药物递送应用的近红外荧光聚乙二醇化聚(RGD)类蛋白聚合物及纳米颗粒的工程化
RSC Adv. 2020 Sep 16;10(57):34364-34372. doi: 10.1039/d0ra06069k.
9
Preparation and characterization of nanoparticles containing an atypical antipsychotic agent.含非典型抗精神病药物纳米颗粒的制备与表征
Nanomedicine (Lond). 2007 Apr;2(2):233-40. doi: 10.2217/17435889.2.2.233.
10
Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.细胞穿透肽与聚乳酸-乙醇酸共聚物-聚乙二醇纳米颗粒的偶联改善了眼部药物递送。
Int J Nanomedicine. 2015 Jan 27;10:609-31. doi: 10.2147/IJN.S71198. eCollection 2015.

引用本文的文献

1
Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules .RGD修饰的载姜黄素壳聚糖/全氟己烷纳米胶囊的制备及其抗癌性能评价
Heliyon. 2022 Jul 11;8(7):e09931. doi: 10.1016/j.heliyon.2022.e09931. eCollection 2022 Jul.
2
Evaluating Non-Conventional Chitosan Sources for Controlled Release of Risperidone.评估用于利培酮控释的非常规壳聚糖来源。
Polymers (Basel). 2022 Mar 26;14(7):1355. doi: 10.3390/polym14071355.
3
Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy.

本文引用的文献

1
Poly-Lactic Acid: Production, Applications, Nanocomposites, and Release Studies.聚乳酸:生产、应用、纳米复合材料及释放研究
Compr Rev Food Sci Food Saf. 2010 Sep;9(5):552-571. doi: 10.1111/j.1541-4337.2010.00126.x.
2
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain.血脑屏障与蛋白质和基因治疗药物向脑内的递送
Front Aging Neurosci. 2020 Jan 10;11:373. doi: 10.3389/fnagi.2019.00373. eCollection 2019.
3
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
用于个性化癌症治疗的包裹协同药物的肿瘤靶向荧光类蛋白纳米胶囊
Pharmaceuticals (Basel). 2021 Jul 6;14(7):648. doi: 10.3390/ph14070648.
4
Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications.用于药物递送应用的阿霉素封装及TRAIL偶联的聚(RGD)类蛋白纳米胶囊的工程设计
Polymers (Basel). 2020 Dec 16;12(12):2996. doi: 10.3390/polym12122996.
5
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.纳米载体药物传递系统治疗神经精神疾病:优势与局限。
Molecules. 2020 Nov 13;25(22):5294. doi: 10.3390/molecules25225294.
载利培酮壳聚糖纳米粒的鼻腔给药制剂及生物药剂学评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1342-1350. doi: 10.1080/03639045.2019.1619759. Epub 2019 Jun 3.
4
Natural biodegradable polymers based nano-formulations for drug delivery: A review.基于天然可生物降解聚合物的纳米制剂用于药物传递:综述。
Int J Pharm. 2019 Apr 20;561:244-264. doi: 10.1016/j.ijpharm.2019.03.011. Epub 2019 Mar 6.
5
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies.用于癌症和神经退行性疾病治疗中药物递送应用的生物相容性聚合物纳米颗粒
J Funct Biomater. 2019 Jan 8;10(1):4. doi: 10.3390/jfb10010004.
6
Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.人类衣原体疫苗的未来:自佐剂可生物降解纳米颗粒作为安全疫苗递送载体的潜力。
Expert Rev Vaccines. 2018 Mar;17(3):217-227. doi: 10.1080/14760584.2018.1435279. Epub 2018 Feb 6.
7
Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.奥氮平固体脂质纳米粒系统用于急性期精神分裂症治疗的设计与体内评价:抗精神病潜力及不良反应研究
Eur J Pharm Sci. 2017 Jun 15;104:315-325. doi: 10.1016/j.ejps.2017.03.050. Epub 2017 Apr 11.
8
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.纳米颗粒介导的脑内药物递送:克服血脑屏障治疗神经退行性疾病。
J Control Release. 2016 Aug 10;235:34-47. doi: 10.1016/j.jconrel.2016.05.044. Epub 2016 May 18.
9
Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.作为基因载体的生物相容性和可生物降解纳米粒子的最新进展。
Expert Opin Biol Ther. 2016 Jun;16(6):771-85. doi: 10.1517/14712598.2016.1169269. Epub 2016 Apr 4.
10
Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy.用于p53癌症基因治疗的非病毒递送系统
Curr Med Chem. 2015;22(35):4118-36. doi: 10.2174/0929867322666151001121601.